Related Experiment Videos
Steroid-induced iatrogenic disease after treating for pseudothrombocytopenia
A Sharma1, Lexley M Pinto Pereira, K Capildeo
1Faculty of Medical Sciences, The University of the West Indies, St Augustine, Trinidad and Tobago, West Indies.
Abstract:
Pseudothrombocytopenia, a spontaneous in vitro occurrence after the addition of anticoagulant to blood, causes clumping of platelets resulting in a spurious observation of low platelet counts (<10,000/μL) without any associated hemorrhagic manifestations. We describe a 46-year-old male patient who was diagnosed with immune thrombocytopenic purpura (ITP) based on a reported platelet count of 22,000/μL. He was prescribed high-dose glucocorticoid therapy, up to 60 mg of prednisolone daily for over a year. After repeated hospital admissions, he came under our care as an emergency admission for nonketotic hyperosmolar hyperglycemia. He was diabetic, osteopenic, and had been treated for tuberculosis, all likely consequences of prolonged glucocorticoid therapy. In the presence of persistent platelet counts below 10,000/μL, and without associated clinical hematological manifestations of ITP, a smear of citrated blood was examined and a platelet count of 215,000/μL was observed. This case highlights the possible consequences of misdiagnosis of pseudothrombocytopenia. Failure to recognize this phenomenon may lead to debilitating iatrogenic disease.
Insights
Misdiagnosing pseudothrombocytopenia as immune thrombocytopenic purpura (ITP) can lead to unnecessary, harmful glucocorticoid treatment. Correctly identifying platelet clumping prevents debilitating iatrogenic complications.
Area of Science:
- Hematology
- Clinical Pathology
Background:
- Immune thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by low platelet counts.
- Pseudothrombocytopenia is an artifactual decrease in platelet count due to in vitro platelet clumping.
Observation:
- A 46-year-old male initially diagnosed with ITP based on a platelet count of 22,000/μL received over a year of high-dose glucocorticoid therapy.
- The patient developed diabetes, osteopenia, and was treated for tuberculosis, likely due to prolonged glucocorticoid use.
- Despite persistent low platelet counts (<10,000/μL) and absence of hemorrhagic symptoms, a citrated blood smear revealed a corrected platelet count of 215,000/μL.
Findings:
- The patient's low platelet count was a result of pseudothrombocytopenia, not ITP.
- Prolonged glucocorticoid therapy, prescribed due to misdiagnosis, caused significant iatrogenic complications.
Implications:
- Failure to recognize pseudothrombocytopenia can lead to misdiagnosis and inappropriate, potentially harmful treatments.
- Accurate laboratory diagnostics are crucial to avoid unnecessary medical interventions and associated patient harm.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Cushing Syndrome I: Introduction
Drug toxicity: Idiosyncratic Reactions
Cushing Syndrome II: Pathophysiology
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids